JB/CALL/POLE GROU/25/0.1/20.12.24 | Market Closed - Swiss Exchange 11:20:00 2024-06-28 EDT | ||
| 0.72 CHF | -6.49% |
|
| 1 month | -31.43% | ||
| 3 months | -20.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 0.72 | -6.49% |
| 24-06-27 | 0.77 | +1.32% |
| 24-06-26 | 0.76 | -7.32% |
| 24-06-25 | 0.82 | -8.89% |
| 24-06-24 | 0.9 | -2.17% |
Delayed Quote Swiss Exchange
Last update June 28, 2024 at 11:20 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Bank Julius Bär |
| PPZWJB | |
| ISIN | CH1280666236 |
| Date issued | 2023-08-14 |
| Strike | 25 CHF |
| Maturity | 2024-12-20 (172 Days) |
| Parity | 10 : 1 |
| Emission price | 0.62 CHF |
| Emission volume | N/A |
| Settlement | Beides |
| Currency | CHF |
Technical Indicators
| Highest since issue | 1.14 CHF |
|---|---|
| Lowest since issue | 0.1 CHF |
| Spread | 0.01 CHF |
| Spread % | 1.37% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
29.51
EUR
Average target price
26.74
EUR
Spread / Average Target
-9.39%
- Stock Market
- Warrants
- PPZWJB Warrant
